Posters

Micropulse laser 532 um (green) treatment in recurrent and chronic central serous chorioretinopathy

Poster Details

First Author: M.Genaidy EGYPT

Co Author(s):                                 

Abstract Details



Purpose:

To assess treatment with IRIDEX IQ 532™ (green) subthreshold micropulse laser in patients with recurrent and chronic central serous chorioretinopathy (cCSC).

Setting:

Ophthalmology department, Faculty of Medicine, Minia University, Minia, Egypt

Methods:

This retrospective study included 27 patients treated with a 532-nm SML (Iridex) for CSC. 12 cases had recurrent type and 15 case had chronic CSC. Assessment included visual acuity (VA), central retinal thickness (CRT) and resolution of SRF

Results:

Follow-up (mean 6 months), 100% of the recurrent type completely cured between one and 3 months and the CRT decreased (mean 130 um). 80% of the chronic cases responded to treatment between 3 to 9 months and the CRT decreased (mean 86 um). VA improved in both groups. No complications from the treatment were detected in all imaging techniques.

Conclusions:

The IQ 532™ (green) SML is an effective treatment for recurrent and chronic CSC

Back to previous
EURETINA, Temple House, Temple Road, Blackrock, Co Dublin. | Phone: 00353 1 2100092 | Fax: 00353 1 2091112 | Email: euretina@euretina.org

Privacy policyHotel Terms and Conditions Cancellation policy